11530 Federal Register / Vol. 86, No. 36 / Thursday, February 25, 2021 / Notices 

demand approximately two weeks after 

the event. To view the live event, visit 

http://fdic.windrosemedia.com. To view 

the recording, visit http://

fdic.windrosemedia.com/index.php?

category=Advisory+Committee+State+

Regulators. If you require a reasonable 

accommodation to participate, please 

contact DisabilityProgram@fdic.gov or 

call 703–562–2096 to make necessary 

arrangements. 

DATES: Thursday, March 18, 2021, from 

1:00 p.m. to 4:30 p.m. 

FOR FURTHER INFORMATION CONTACT: 

Requests for further information 

concerning the meeting may be directed 

to Mrs. Debra D. Decker, Committee 

Management Officer of the FDIC, at 

(202) 898–8748. 

SUPPLEMENTARY INFORMATION: 

Agenda: The agenda will include a 

discussion of a variety of current and 

emerging issues that have potential 

implications regarding the regulation 

and supervision of state-chartered 

financial institutions. The agenda is 

subject to change. Any changes to the 

agenda will be announced at the 

beginning of the meeting. 

Type of Meeting: This meeting of the 

Advisory Committee of State Regulators 

will be Webcast live via the internet 

http://fdic.windrosemedia.com. For 

optimal viewing, a high-speed internet 

connection is recommended. 

Federal Deposit Insurance Corporation. 

Dated at Washington, DC, on February 19, 

2021. 

James Sheesley, 

Assistant Executive Secretary. 

[FR Doc. 2021–03839 Filed 2–24–21; 8:45 am] 

BILLING CODE 6714–01–P 

FEDERAL RESERVE SYSTEM 

Notice of Proposals To Engage in or 

To Acquire Companies Engaged in 

Permissible Nonbanking Activities 

The companies listed in this notice 

have given notice under section 4 of the 

Bank Holding Company Act (12 U.S.C. 

1843) (BHC Act) and Regulation Y, (12 

CFR part 225) to engage de novo, or to 

acquire or control voting securities or 

assets of a company, including the 

companies listed below, that engages 

either directly or through a subsidiary or 

other company, in a nonbanking activity 

that is listed in § 225.28 of Regulation Y 

(12 CFR 225.28) or that the Board has 

determined by Order to be closely 

related to banking and permissible for 

bank holding companies. Unless 

otherwise noted, these activities will be 

conducted throughout the United States. 

The public portions of the 

applications listed below, as well as 

other related filings required by the 

Board, if any, are available for 

immediate inspection at the Federal 

Reserve Bank(s) indicated below and at 

the offices of the Board of Governors. 

This information may also be obtained 

on an expedited basis, upon request, by 

contacting the appropriate Federal 

Reserve Bank and from the Board’s 

Freedom of Information Office at 

https://www.federalreserve.gov/foia/ 

request.htm. Interested persons may 

express their views in writing on the 

question whether the proposal complies 

with the standards of section 4 of the 

BHC Act. 

Unless otherwise noted, comments 

regarding the applications must be 

received at the Reserve Bank indicated 

or the offices of the Board of Governors, 

Ann E. Misback, Secretary of the Board, 

20th Street and Constitution Avenue 

NW, Washington, DC 20551–0001, not 

later than March 12, 2021. 

A. Federal Reserve Bank of 

Minneapolis (Chris P. Wangen, 

Assistant Vice President), 90 Hennepin 

Avenue, Minneapolis, Minnesota 

55480–0291: 

1. Hazen Bancorporation, Inc., Hazen, 

North Dakota; through its subsidiary 

bank holding company, North Star 

Holding Company, Inc., and its 

subsidiary bank, Unison Bank, both of 

Jamestown, North Dakota, to indirectly 

retain voting shares of AccuData 

Services, Inc., Park River, North Dakota, 

and thereby engage in certain data 

processing activities pursuant to section 

225.28(b)(14)(i) of the Board’s 

Regulation Y. 

Board of Governors of the Federal Reserve 

System, February 19, 2021. 

Michele Taylor Fennell, 

Deputy Associate Secretary of the Board. 

[FR Doc. 2021–03843 Filed 2–24–21; 8:45 am] 

BILLING CODE P 

FEDERAL RESERVE SYSTEM 

Change in Bank Control Notices; 

Acquisitions of Shares of a Bank or 

Bank Holding Company 

The notificants listed below have 

applied under the Change in Bank 

Control Act (Act) (12 U.S.C. 1817(j)) and 

§ 225.41 of the Board’s Regulation Y (12 

CFR 225.41) to acquire shares of a bank 

or bank holding company. The factors 

that are considered in acting on the 

applications are set forth in paragraph 7 

of the Act (12 U.S.C. 1817(j)(7)). 

The public portions of the 

applications listed below, as well as 

other related filings required by the 

Board, if any, are available for 

immediate inspection at the Federal 

Reserve Bank(s) indicated below and at 

the offices of the Board of Governors. 

This information may also be obtained 

on an expedited basis, upon request, by 

contacting the appropriate Federal 

Reserve Bank and from the Board’s 

Freedom of Information Office at 

https://www.federalreserve.gov/foia/ 

request.htm. Interested persons may 

express their views in writing on the 

standards enumerated in paragraph 7 of 

the Act. 

Comments regarding each of these 

applications must be received at the 

Reserve Bank indicated or the offices of 

the Board of Governors, Ann E. 

Misback, Secretary of the Board, 20th 

Street and Constitution Avenue NW, 

Washington DC 20551–0001, not later 

than March 12, 2021. 

A. Federal Reserve Bank of St. Louis 

(David L. Hubbard, Senior Manager) 

P.O. Box 442, St. Louis, Missouri 

63166–2034. Comments can also be sent 

electronically to 

Comments.applications@stls.frb.org: 

1. Virginia F. Sapp Trust, Virginia F. 

Sapp, as trustee, both of St. Louis, 

Missouri; the Samuel D. Gohn Trust, 

Samuel D. Gohn, as trustee, the Billie 

Kay Gohn Trust, Billie Kay Gohn, as 

trustee, the Gohn Qualified Spousal 

Trust, David M. Gohn, as trustee, the 

Courtney G. Beykirch Revocable Trust, 

Courtney G. Beykirch, as trustee, four 

Irrevocable Trusts Established for a 

Minor Child, Courtney G. Beykirch and 

David M. Gohn, as co-trustees, and 

Caroline G. Beykirch, all of West Plains, 

Missouri; a Minor Child Irrevocable 

Trust, West Plains, Missouri; Jennifer G. 

Mahaffey, Rogersville, Missouri, and 

Courtney G. Beykirch, West Plains, 

Missouri, as co-trustees; the Jennifer G. 

Mahaffey Trust, Jennifer G. Mahaffey, as 

trustee, both of Rogersville, Missouri; 

Amanda Sapp, Oregon City, Oregon; 

and Jerod Sapp, Corvallis, Oregon; to 

retain voting shares of West Plains 

Bancshares, Inc., and thereby indirectly 

retain voting shares of West Plains Bank 

and Trust Company, both of West 

Plains, Missouri. 

2. Michael F. Bender and Diane M. 

Bender, both of Farmington, Missouri; 

Tyler M. Bender and Kelly L. Bender, 

both of Webster Groves, Missouri; Jacob 

J. Bender and JJB Capital, LLC, both of 

Dallas, Texas; and Abby M. Kimrey and 

Jordan Kimrey, both of St. Louis, 

Missouri; as a family control group, and 

a group acting in concert, to retain 

voting shares of Midwest Regional 

Bancorp, Inc., and thereby indirectly 

retain voting shares of Midwest 

Regional Bank, both of Festus, Missouri. 

Federal Register / Vol. 86, No. 36 / Thursday, February 25, 2021 / Notices 11531 

B. Federal Reserve Bank of Kansas 

City (Dennis Denney, Assistant Vice 

President) 1 Memorial Drive, Kansas 

City, Missouri 64198–0001: 

1. Lance L. White, as co-trustee of the 

Lance L. White Revocable Trust and as 

trustee of the Lance L. White Irrevocable 

Trust, and Cherlyn D. White, as trustee 

of the Cherlyn D. White-Conklin 

Irrevocable Trust and as co-trustee of 

the Cherlyn White-Conklin Trust, all of 

Wamego, Kansas; and Monte W. White, 

individually, and as trustee of the MWW 

Irrevocable Trust #1, both of Salina, 

Kansas; as members of the White Family 

Group, a group acting in concert, to 

retain voting shares of Wamego 

Bancshares, Inc., and thereby indirectly 

retain voting shares of Bank of the Flint 

Hills, both of Wamego, Kansas. 

Additionally, Kara L. White, as cotrustee of the Lance L. White Revocable 

Trust, Cherlyn White-Conklin Trust, 

Erich Conklin, as co-trustee, and certain 

minor children, all of Salina and 

Wamego, Kansas; to join the White 

Family Group, and retain voting shares 

of Wamego Bancshares, Inc., and 

thereby indirectly retain voting shares of 

Bank of the Flint Hills. 

Board of Governors of the Federal Reserve 

System, February 19, 2021. 

Michele Taylor Fennell, 

Deputy Associate Secretary of the Board. 

[FR Doc. 2021–03841 Filed 2–24–21; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[Docket No. CDC–2021–0021] 

Advisory Committee on Immunization 

Practices (ACIP) 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of meeting and request 

for comment. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, the 

Centers for Disease Control and 

Prevention (CDC), announces the 

following meeting of the Advisory 

Committee on Immunization Practices 

(ACIP). This meeting is open to the 

public. Time will be available for public 

comment. The meeting will be webcast 

live via the World Wide Web. 

DATES: The meeting will be held on 

February 28, 2021–March 1, 2021, from 

10:00 a.m. to 5:00 p.m. EDT (times 

subject to change). Written comments 

must be received on or before March 1, 

2021. 

ADDRESSES: For more information on 

ACIP please visit the ACIP website: 

http://www.cdc.gov/vaccines/acip/ 

index.html. 

You may submit comments, identified 

by Docket No. CDC–2021–0021 by any 

of the following methods: 

• Federal eRulemaking Portal: 

https://www.regulations.gov. Follow the 

instructions for submitting comments. 

• Mail: Docket No. CDC–2021–0021, 

c/o Attn: ACIP Meeting, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS H24–8, Atlanta, 

GA 30329–4027. 

Instructions: All submissions received 

must include the Agency name and 

Docket Number. All relevant comments 

received in conformance with the 

https://www.regulations.gov suitability 

policy will be posted without change to 

https://www.regulations.gov, including 

any personal information provided. For 

access to the docket to read background 

documents or comments received, go to 

https://www.regulations.gov. 

Written public comments submitted 

24 hours prior to the ACIP meeting will 

be provided to ACIP members before the 

meeting. 

FOR FURTHER INFORMATION CONTACT: 

Stephanie Thomas, ACIP Committee 

Management Specialist, Centers for 

Disease Control and Prevention, 

National Center for Immunization and 

Respiratory Diseases, 1600 Clifton Road 

NE, MS–H24–8, Atlanta, GA 30329– 

4027; Telephone: 404–639–8367; Email: 

ACIP@cdc.gov. 

SUPPLEMENTARY INFORMATION: In 

accordance with 41 CFR 102–3.150(b), 

less than 15 calendar days notice is 

being given for this meeting due to the 

exceptional circumstances of the 

COVID–19 pandemic and rapidly 

evolving COVID–19 vaccine 

development and regulatory processes. 

The Secretary of Health and Human 

Services has determined that COVID–19 

is a Public Health Emergency. 

Purpose: The committee is charged 

with advising the Director, CDC, on the 

use of immunizing agents. In addition, 

under 42 U.S.C. 1396s, the committee is 

mandated to establish and periodically 

review and, as appropriate, revise the 

list of vaccines for administration to 

vaccine-eligible children through the 

Vaccines for Children (VFC) program, 

along with schedules regarding dosing 

interval, dosage, and contraindications 

to administration of vaccines. Further, 

under provisions of the Affordable Care 

Act, section 2713 of the Public Health 

Service Act, immunization 

recommendations of the ACIP that have 

been approved by the Director of the 

Centers for Disease Control and 

Prevention and appear on CDC 

immunization schedules must be 

covered by applicable health plans. 

Matters To Be Considered: The agenda 

will include discussions on COVID–19 

vaccines. A recommendation vote is 

scheduled. Agenda items are subject to 

change as priorities dictate. For more 

information on the meeting agenda visit 

https://www.cdc.gov/vaccines/acip/ 

meetings/meetings-info.html. 

Meeting Information: The meeting 

will be webcast live via the World Wide 

Web; for more information on ACIP 

please visit the ACIP website: http://

www.cdc.gov/vaccines/acip/index.html. 

Public Participation 

Interested persons or organizations 

are invited to participate by submitting 

written views, recommendations, and 

data. Please note that comments 

received, including attachments and 

other supporting materials are part of 

the public record and are subject to 

public disclosure. Do not include any 

information in your comment or 

supporting materials that you consider 

confidential or inappropriate for public 

disclosure. If you include your name, 

contact information, or other 

information that identifies you in the 

body of your comments, that 

information will be on public display. 

CDC will review all submissions and 

may choose to redact, or withhold, 

submissions containing private or 

proprietary information such as Social 

Security numbers, medical information, 

inappropriate language, or duplicate/ 

near duplicate examples of a mass-mail 

campaign. CDC will carefully consider 

all comments submitted into the docket. 

CDC does not accept comment by email. 

Written Public Comment: Written 

comments must be received on or before 

March 1, 2021. Oral Public Comment: 

This meeting will include time for 

members of the public to make an oral 

comment. Oral public comment will 

occur before any scheduled votes 

including all votes relevant to the 

ACIP’s Affordable Care Act and 

Vaccines for Children Program roles. 

Priority will be given to individuals 

who submit a request to make an oral 

public comment before the meeting 

according to the procedures below. 

Procedure for Oral Public Comment: 

All persons interested in making an oral 

public comment at the February 28, 

2021–March 1, 2021 ACIP meeting must 

submit a request at http://www.cdc.gov/ 

vaccines/acip/meetings/ no later than 

11:59 p.m., EDT, February 25, 2021 

according to the instructions provided.